Jones Financial Companies’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Buy
252,329
+181,273
+255% +$15.2M 0.01% 634
2026
Q1
$5.64M Buy
71,056
+58,505
+466% +$4.82M ﹤0.01% 1037
2025
Q4
$1.07M Sell
12,551
-1,744
-12% -$143K ﹤0.01% 1202
2025
Q3
$1.09M Buy
14,295
+3,721
+35% +$291K ﹤0.01% 1097
2025
Q2
$827K Buy
10,574
+619
+6% +$46.2K ﹤0.01% 1081
2025
Q1
$707K Buy
9,955
+1,941
+24% +$139K ﹤0.01% 995
2024
Q4
$593K Buy
8,014
+1,329
+20% +$93K ﹤0.01% 932
2024
Q3
$445K Buy
6,685
+5,295
+381% +$385K ﹤0.01% 865
2024
Q2
$128K Buy
1,390
+723
+108% +$64K ﹤0.01% 963
2024
Q1
$63.7K Buy
667
+296
+80% +$24.9K ﹤0.01% 685
2023
Q4
$28.3K Buy
371
+37
+11% +$2.57K ﹤0.01% 546
2023
Q3
$23.1K Sell
334
-60
-15% -$4.82K ﹤0.01% 420
2023
Q2
$37.2K Sell
394
-1
-0.3% -$87 ﹤0.01% 379
2023
Q1
$32.7K Buy
+395
New +$31K ﹤0.01% 383
2022
Q2
Sell
-3,600
Closed -$424K 765
2022
Q1
$424K Buy
3,600
+2,505
+229% +$281K ﹤0.01% 201
2021
Q4
$142K Buy
+1,095
New +$128K ﹤0.01% 285
2021
Q3
Sell
-434
Closed -$45K 646
2021
Q2
$45K Buy
434
+402
+1,256% +$37.9K ﹤0.01% 320
2021
Q1
$3K Buy
+32
New +$2.71K ﹤0.01% 701

Other funds holding EW

Jones Financial Companies's EW Position: Q2 2026 in Review

Jones Financial Companies increased its Edwards Lifesciences (EW) stake by 255% in Q2 2026, buying an estimated $15.2M and bringing the position to 252,329 shares worth $22.9M. The position accounts for 0.01% of the portfolio, ranked #634.

Jones Financial Companies first reported a position in EW in Q1 2021 and has held it in 18 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Jones Financial Companies held 252,329 shares of Edwards Lifesciences worth $22.9M as of Q2 2026.
  • Jones Financial Companies bought 181,273 Edwards Lifesciences shares in Q2 2026, an estimated $15.2M.
  • Edwards Lifesciences made up 0.01% of Jones Financial Companies's portfolio in Q2 2026, its #634 holding.
  • Jones Financial Companies first reported a position in Edwards Lifesciences in Q1 2021 and has held it in 18 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.